NORTHWEST BIOTHERAPEUTICS INC
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2020 | $395.8M | $32.9M | $10.0M |
| FY2021 | $164.2M | $40.2M | $15.2M |
| FY2022 | $136.4M | $31.3M | $7.0M |
| FY2023 | $74.9M | $27.9M | $2.1M |
| FY2024 | $105.7M | $26.7M | $2.2M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2020 | $395.8M | $32.9M | $10.0M |
| FY2021 | $164.2M | $40.2M | $15.2M |
| FY2022 | $136.4M | $31.3M | $7.0M |
| FY2023 | $74.9M | $27.9M | $2.1M |
| FY2024 | $105.7M | $26.7M | $2.2M |